Endopulse
Latest round
- Seed
Last raised
- May 2025
Total raised
- Undisclosed
Investors
- 1
About Endopulse
Founded in 2025, Endopulse Ltd. specializes in developing advanced medical technologies for cardiac care. The company has not undergone any notable pivots or changes in operations since its inception. It operates out of Or-Yehuda, Israel, and is focused solely on its core mission.EndoPulse is focused on developing a groundbreaking medical device aimed at transforming cardiac care. The core product offering is a revolutionary technology designed to improve diagnosis and treatment outcomes for patients with cardiovascular conditions. While specific functional details remain under wraps due to the company's stealth mode operations, the anticipated applications include enhanced monitoring, diagnostic capabilities, and potential therapeutic interventions for a variety of cardiac ailments. EndoPulse targets a diverse client base, which may encompass hospitals, clinics, and healthcare providers seeking to adopt innovative cardiac care solutions.EndoPulse's revenue model is structured around direct transactions with healthcare providers and institutions, potentially involving both B2B and direct-to-consumer sales avenues. The company's flagship product is positioned for acquisition through standard purchase agreements or leasing options, enhancing accessibility for healthcare facilities. Revenue generation may also include subscription-based models for ongoing software updates or service agreements related to their core medical device. While specific pricing plans for their offerings are not disclosed, the transaction structure is designed to accommodate varying client budgets, ranging from large hospital systems to smaller clinics.Endopulse Ltd. aims to expand its product portfolio with the introduction of new medical devices tailored for cardiac care, with anticipated launches scheduled for late 2025. The company plans to penetrate additional markets, focusing on North America and Europe by the end of 2026.
Who invested in Endopulse
1 investor across 1 round
See all investors in Endopulse
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 1, 2025
Amount
Undisclosed
Investors
Questions about Endopulse
Who invested in Endopulse?
Endopulse has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endopulse raised?
Endopulse has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Endopulse last raise money?
Endopulse's most recent round on record is a Seed, in May 2025.
What does Endopulse do?
Founded in 2025, Endopulse Ltd.
Where is Endopulse headquartered?
Endopulse is headquartered in Or-Yehuda, Israel.
Which VCs invest in companies like Endopulse?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Endopulse's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Endopulse? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.